PULM Pulmatrix Inc

Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.

$1.29
As of 04/09/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2014
Outstanding shares:  56,249,062
Average volume:  1,013,098
Market cap:   $72,561,290
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74584P202
ISIN:        US74584P2020
Sedol:      BJHTCB7

---

Valuation   (See tab for details)

---

PE ratio:   -3.76
PB ratio:   1.75
PS ratio:   6.82
Return on equity:   -70.91%
Net income %:   -154.12%